PHIM Responsive Header

Tag: Lab

  • ISO 15189:2022 Accreditation.

    ISO 15189:2022 Accreditation.

    Malawi’s National Genomic Sequencing Reference Laboratory Achieves ISO 15189:2022 Accreditation | PHIM
    Laboratory Accreditation Milestone

    Malawi’s National Genomic Sequencing Reference Laboratory Achieves ISO 15189:2022 Accreditation

    Dr. Mirrium Nyenje Happy Abraham Manda |
    October 2026 6 min read Lilongwe
    SADCAS Assessors and PHIM Laboratory Staff during the ISO 15189:2022 Assessment
    ISO 15189:2022 Verified
    SADCAS assessors and PHIM laboratory officers following the successful initial assessment on 8–9 October 2026 in Lilongwe. Photo: Chris Kaudzu

    National Genomic Sequencing Reference Laboratory (NGSRL) at the Public Health Institute of Malawi (PHIM) has been recommended for accreditation to ISO 15189:2022, the gold standard for quality and competence in medical laboratories.

    The Southern African Development Community Accreditation Service (SADCAS) officially recommended the laboratory for accreditation following a rigorous initial on-site assessment conducted on 8–9 October 2026. The assessment concluded on a high note, with SADCAS assessors and PHIM leadership celebrating the culmination of years of dedicated work by the laboratory team to establish world-class genomic quality systems.

    International Recognition for National Data

    “Accreditation to ISO 15189:2022 is far more than a technical requirement. It is a strategic investment in the quality, credibility, and long-term sustainability of Malawi’s public health system—ensuring that our genomic data and disease surveillance results command global confidence.”

    What the NGSRL Does

    Operating under the Ministry of Health, PHIM plays a central role in strengthening Malawi’s public health laboratory system, epidemic intelligence, disease surveillance, and evidence-informed decision-making. As a specialized national facility, the NGSRL delivers crucial diagnostic and genomic surveillance services for priority pathogens, including:

    • Viral Threats: HIV, Influenza viruses, mpox virus, SARS-CoV-2, and epidemic-prone viral hemorrhagic fevers.
    • Bacterial & Parasitic Pathogens: Mycobacterium tuberculosis, Vibrio cholerae, and malaria parasites (Plasmodium falciparum).
    • Antimicrobial Resistance (AMR): Monitoring resistant superbugs and bacterial strain profiles nationwide.

    By generating molecular data for pathogen characterization, tracking transmission pathways, monitoring drug resistance, and investigating disease outbreaks, the NGSRL equips clinical managers and national public health programs with reliable, technically valid results.

    SADCAS Lead Assessor reviewing laboratory documentation and quality manuals
    Rigorous Document & Protocol Review SADCAS assessors evaluating NGSRL’s standard operating procedures, validation data, and quality management systems against ISO 15189:2022 standards.
    SADCAS Assessors and PHIM Scientists discussing technical genomics procedures
    Technical Competence Verification Assessors observing sequencing workflows, equipment calibration logs, and biosafety controls inside the NGSRL facility.

    A Capability Built Over Several Years

    In-country genomic sequencing is a transformative advancement for Malawi. Prior to establishing local sequencing infrastructure, specialized diagnostic samples had to be shipped to regional hubs in South Africa, Uganda, or Kenya—a process that often introduced logistical delays during health emergencies.

    Malawi’s journey gained momentum during the COVID-19 pandemic. Having detected the country’s first case in April 2020, national reference scientists deployed low-throughput equipment to sequence Malawi’s first batch of COVID-19 samples in June 2021, dramatically reducing reliance on external laboratories.

    Today, genomics is formally anchored in national policy. On 3 July 2025, the Ministry of Health launched the updated National Genomic Surveillance Implementation Plan (2025–2030), outlining a roadmap for integrating genomic technologies across public health facilities. SADCAS accreditation ensures this strategy rests on independently verified laboratory quality.

    Meeting the Updated ISO 15189:2022 Standard

    The timing of this achievement carries significance. Published on 6 December 2022, the updated ISO 15189:2022 edition replaced the earlier 2012 standard, placing greater emphasis on risk management, patient welfare, and continuous process control. SADCAS established a three-year transition window ending 5 December 2025. By achieving compliance, NGSRL operates under the latest, most stringent global standard.

    Why SADCAS Accreditation Matters

    As a multi-economy accreditation body recognized across SADC Member States, SADCAS operates under the Mutual Recognition Agreements (MRAs) of the International Laboratory Accreditation Cooperation (ILAC) and the African Accreditation Cooperation (AFRAC).

    This means sequencing results produced by Malawi’s NGSRL are internationally recognized. Whether reporting new viral variants, tracking regional drug resistance, or submitting epidemiological data to global repositories, accreditation guarantees that Malawi’s public health data meets uncompromising international quality benchmarks.

    Looking Ahead

    Accreditation is an ongoing commitment rather than a static destination. Moving forward, PHIM will continue to refine quality workflows, expand technical scopes, and invest in continuous professional development for laboratory staff—ensuring that Malawi remains at the forefront of disease surveillance and epidemic response.

    Share Article:

    Published By

    Moses Nyambalo Phiri

    Ministry of Health, Republic of Malawi

  • Webinar on Malaria Genomics and Quality Assurance in Malawi.

    Webinar on Malaria Genomics and Quality Assurance in Malawi.

    WEBINAR ON | PHIM Malawi
    Malaria Genomics & Quality Assurance

    Webinar on Malaria Genomics
    & Quality Assurance

    Strengthening national diagnostic and surveillance precision across Malawi. Learn about high-fidelity genome sequencing techniques, advanced data integration protocols, and laboratory quality management systems.

    Date & Time

    Wed, 10 Jun | 2 PM – 3 PM CAT

    Contributors

    Happy Abraham Manda Christopher Misomali Dr. Mirriam Nyenje

    Keynote Presenters

    Edwin Chitandale

    Edwin Chitandale

    Medical Laboratory Scientist & QMS Expert
    QA Coordinator, PHIM

    Edwin Chitandale serves as the QA Coordinator at PHIM and acts as a QMS consultant to accreditation, continental, regional, and national bodies. He specializes in implementing, training, and auditing complex standards such as ISO 15189, ISO/IEC 17025, and ISO 35001. A recipient of the Zikomo Award of Health Excellence for his COVID-19 response role and a 2024 World Haemophilia Foundation grant, he is currently pursuing his Master in Laboratory Sciences-Haematology.

    Happy Manda

    Happy Manda

    Senior Medical Laboratory Scientist
    National Public Health Laboratory, PHIM

    Happy Manda is a Senior Medical Laboratory Scientist at the Public Health Institute of Malawi, stationed at the National Public Health Laboratory. He specializes in molecular biology diagnostic procedures and target gene sequencing workflows. His research interests focus on tracking drug-resistance mutations in Plasmodium falciparum. He acts as a key facilitator for pathogen surveillance training operations across secondary and tertiary healthcare centers in Malawi.

    Technical Delivery

    Deep dive into lab standards, next-generation malaria genomics data processing, and clinical QMS execution models.

    • Malaria Gene Mutation Tracking
    • ISO Standards Audits (15189, 17025)
    • Statistical Quality Control Validation

    Seminar Program

    Wednesday, 10th June
    02:00 PM

    Welcome & Session Overview

    Introduction to Pathogen Genomics & PHIM Frameworks

    02:10 PM

    Malaria Genomic Sequencing

    Next-Generation Sequencing and Resistance Mapping: Happy Manda

    02:30 PM

    QMS & One Health Audit Standards

    Implementing ISO Standards (15189, 17025) & Method Validation: Edwin Chitandale

    02:50 PM

    Interactive Panel Q&A Session

    Open Floor: Answering Quality Control & Diagnostic Challenges

    Webinar Registration

    Join Happy Manda and Edwin Chitandale for this specialized training session.

    Research & Resources

    Authored & Published By

    Moses Nyambalo Phiri

    Public Health Institute of Malawi

    Ministry of Health, Republic of Malawi

    Building a Healthier Malawi, Together!

  • CIHEB Initiative Work plan: Accelerating Malawi’s PEPFAR Laboratory Logistics and Infrastructure for Quality 2.0(AMPLIFY 2.0).

    CIHEB Initiative Work plan: Accelerating Malawi’s PEPFAR Laboratory Logistics and Infrastructure for Quality 2.0(AMPLIFY 2.0).

    CIHEB – AMPLIFY 2.0.

    Lilongwe, Malawi – May 30th, 2025.
    by
    Moses Nyambalo Phiri in collaboration with Happy Abraham Manda and Settie Kanyanda.

    Centre for International Health, Education, and Biosecurity (CIHEB), a locally-led organization established in 2023 as a successor to Maryland Global Initiatives Corporation (MGIC) Malawi, recently briefed the National Public Health Laboratory (NPHL) management on its new initiative: Accelerating Malawi’s PEPFAR Laboratory Logistics and Infrastructure for Quality 2.0 (AMPLIFY 2.0). This project is set to significantly enhance Malawi’s diagnostic and treatment monitoring services, biosafety measures, and overall laboratory capabilities.

    The NPHL, a core pillar of the Public Health Institute of Malawi (PHIM), serves as the national reference laboratory, supporting a vast network of laboratories across the country. It comprises specialized subsections, including Genomic Sequencing, Tuberculosis, Parasitology, HIV, Microbiology, Biochemistry, Haematology, Nutrition, and Viral/Influenza. While the NPHL receives support from various partners, including CIHEB, a key challenge highlighted during the meeting was the lack of adequate space for reference laboratories at PHIM. This concern was voiced by Mr. Joseph Bitilinyu Bangoh, who chaired the meeting, and Dr. Mirriam Nyenje, and echoed by Chiefs Henry Limula, Sheinton Kacheche, Mabvuto Chiwaula, and Dorothy Donata Kalata. Chief Dorothy Kalata specifically advocated for support for the Gene Xpert system and urged CIHEB to incorporate these activities into the project plan.

    PHIM-NPHL management team listening to the presentation

    AMPLIFY 2.0: Key Objectives and Proposed Activities
    AMPLIFY 2.0 aims to achieve several critical objectives to strengthen Malawi’s public health laboratory system:

    a. Scaling Up Multi-Disease and Integrated Diagnosis and Treatment Monitoring Services:

    This includes developing and reviewing testing procedures, creating training packages and curricula for ECHO sessions focused on emerging, re-emerging, and priority diseases. CIHEB plans to conduct virtual immersion training for subject matter experts, support laboratories with benchmarking and twinning programs for capacity building, and strengthen the Ministry of Health’s (MOH) ability to coordinate and oversee national diagnostic services. Furthermore, the project will support training for district lab technicians in all aspects of testing and data use, assist in developing Standard Operating Procedures (SOPs) to enhance the proficiency testing (PT) program, and aid PHIM in reviewing and developing method validation/verification procedures. CIHEB will also facilitate the resolution of corrective actions, track validated methods, disseminate results, and collaborate with PHIM QA, HTSS-D, and PAM to develop tools for monitoring method validation/verification, post-market surveillance, and equipment maintenance. The project will also review and disseminate the national quality assurance framework.

    b. Strengthening Biosafety, Biosecurity, and Waste Management:

    Strengthening MOH Capacity for Coordination and Oversight: This objective focuses on bolstering the MOH’s ability to coordinate and oversee national diagnostic services effectively.

    c. Scaling Up Continuous Quality Improvement (CQI) in Laboratories and Point-of-Care Testing (POCT) Services:

    CIHEB will support PHIM’s PT program with virtual audit training, conduct national External Quality Assurance (EQA) quarterly review meetings, and enroll laboratories in PT and inter-lab comparisons. The project will also facilitate international training for PT scheme managers for new schemes (e.g., TB culture, CD4, emerging diseases) and support PHIM in HIV RT, Syphilis, and Hepatitis B PT and Quality Control (QC) production. Building local capacity for ePT management is also a key component.

    d. Scaling Up POCT CQI:

    This involves training HIV Testing Services (HTS) providers on CQI tools and data use to increase the uptake of quality management systems, conducting biannual SPI-RRT audits, and performing SWOT analyses on CQI tool scalability. Additionally, the project will review and disseminate the national certification framework, facilitate a virtual benchmarking meeting with Tanzania on HIV RT CQI and site-level online PT results submission, and build local capacity for SPI-RRT management.

    f. Scaling Up ECHO Sessions:

    CIHEB will conduct HIV RT ECHO exit assessments, perform desk reviews to identify gaps for ECHO teleconferences, and organize ECHO sessions for HIV RT, EQA, emerging/priority diseases, equipment service, and data use programs. The project will also support the review and development of ECHO curricula for various programs and conduct baseline and exit assessments for new ECHO programs.

    g. Strengthening Genomic Sequencing Capacity:

    CIHEB will link the Genomic Lab LIMS with Africa CDC NIMS, engage with lab training institutions to update curricula to include genomic sequencing, support bioinformatics training, establish a local equipment calibration center, and conduct engagement meetings with stakeholders on genomics and other services.

    h. Establishing a National Accreditation Body:

    CIHEB will support the MOH in establishing a national accreditation body through stakeholder engagement meetings.

    Dr. Miriam Nyenje taking on Genomics concerns in the projects

    Integrated Activities for CQI and Multi-Disease Services
    AMPLIFY 2.0 incorporates several integrated activities to achieve its objectives, including:

    District-Level Support: Quarterly supervisions, mentorships, assessments, and review meetings.
    National Oversight: Spot check visits on district supervision, mentorship, meetings, training, and assessments, along with national corrective actions on method verification/post-market surveillance.
    Data Review: National monthly, quarterly, biannual, and annual data review meetings (virtual and in-person).
    Knowledge Sharing: Regional biannual best practices workshops.
    Targeted Training: District trainings where applicable.
    Virtual Learning: Virtual Immersion ECHO training and IECHO registration for teleconference participants.
    Awareness: District Health Management Team (DHMT) sensitization on new ECHO programs.

    Dr. Oscar Divala making a presentation on CIHEB’s AMPLIFY 2.0 Project

    Essential Procurements and PHIM’s Role

    To facilitate these activities, CIHEB will procure essential supplies, including materials for 13 local PT schemes’ panels, HIV RT QC production, HIV RRT supplies (e.g., digital timers, thermometers), and chemistry and FBC PT materials. The project will also cover NHLS PT subscriptions, facilitate accreditation of the PT program, and support ECHO, ePT, and SPI-RRT registration, including providing ECHO data bundles and courier services.

    CIHEB emphasizes the need for PHIM’s support to successfully implement AMPLIFY 2.0. This includes:

    Facilitating CIHEB’s Introduction to Facilities: Ensuring smooth access and collaboration.
    Coordination on Activity Implementation: Allowing for simultaneous implementation of project activities.
    Identification of Space: Facilitating the identification of space for PT lab renovation or collaboration with other partners on renovations.
    Resource Lobbying: Lobbying for resources from the Ministry of Health for sustainable strategies.

    Dr. Thokozani Kalua answering and clarifying some questions and points raised during the meeting.


    The meeting concluded with Dr. Thokozani Kalua and Dr. Oscar Divala providing further clarifications and presentations on the AMPLIFY 2.0 project and its procurement plans. The collaboration between CIHEB and PHIM is poised to significantly strengthen Malawi’s public health laboratory infrastructure and contribute to improved diagnostic and treatment outcomes across the nation.